Hepatoprotective effects of Ginkgo biloba against carbon tetrachloride induced hepatic injury in rats

K. Ashok Shenoy, S. N. Somayaji, K. L. Bairy

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Objectives: To assess the protective activity of Ginkgo biloba (GB) against CCl4 induced hepatotoxicity in rats and probe into its mechanism of action. Methods: Liver damage was induced in Wistar rats by administering (150-250 g) CCl4 (0.5 ml/kg, i.p.) once daily for 7 days. GB (50 mg/kg, i.p.) was given for one week. Silymarin (200 mg/kg, p.o.) was given as a reference drug. Levels of marker enzymes (AST, ALT, ALP) and total proteins (TP), albumin (Alb) were estimated in serum. A probe into the mechanism of action was attempted by estimating thiobarbituric acid reactive substances (TBARS) and glutathione (GSH) levels in liver homogenates in order to evaluate the degree of lipid peroxidation. Histopathological studies were also done to confirm the biochemical changes. Results: The mean ± SEM serum AST, ALT, ALP levels in control animals were 66.8 ± 4.2, 31.1 ± 2.0 and 445.3 ± 23.1 IU/L respectively whereas in CCl4 treated rats, the level rose to 319.6 ± 22.7, 192.8 ± 16.0 and 809.3 ± 65.3 IU/L respectively. GB reduced the AST, ALT and ALP levels to 55.5 ± 5.3, 36.5 ± 3.6 and 489.6 ± 43.9 IU/L respectively. Silymarin reduced AST, ALT and ALP levels to 51.8 ± 5.2, 30.8 ± 3.4 and 437.8 ± 35.7 IU/L respectively. There was a significant decrease in serum TP and Alb levels after CCl4, which was reversed by GB and silymarin. The tissue mean ± SEM values of TBARS and GSH in control animals were 3.1 ± 0.1 nmol of malondialdehyde/g of wet tissue and 1.9 ± 0.1 mg/g of wet tissue respectively. In CCl4 treated animals, the TBARS and GSH levels were 3.91 ± 0.41 and 1.97 ± 0.11 respectively. GB reduced TBARS to 2.4 ± 0.09 nmol of MDA/g of wet tissue and increased GSH level to 2.4 ± 0.1 mg/g of wet tissue. Silymarin reduced TBARS to 2.1 ± 0.2 nmol of MDA/g of wet tissue and increased GSH level to 2.5 ± 0.17 mg/g of wet tissue. Conclusion: GB has protected the liver from CCl4 damage. Probable mechanism of action is by protection against oxidative damage produced by CCl4.

Original languageEnglish
Pages (from-to)260-266
Number of pages7
JournalIndian Journal of Pharmacology
Volume33
Issue number4
Publication statusPublished - 26-09-2001
Externally publishedYes

Fingerprint

Ginkgo biloba
Carbon Tetrachloride
Thiobarbituric Acid Reactive Substances
Silymarin
Liver
Wounds and Injuries
Malondialdehyde
Serum
Serum Albumin
Lipid Peroxidation
Glutathione
Wistar Rats
Blood Proteins
Albumins
Enzymes
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Ashok Shenoy, K. ; Somayaji, S. N. ; Bairy, K. L. / Hepatoprotective effects of Ginkgo biloba against carbon tetrachloride induced hepatic injury in rats. In: Indian Journal of Pharmacology. 2001 ; Vol. 33, No. 4. pp. 260-266.
@article{34bf268298cf447181c151cdc98b8f3b,
title = "Hepatoprotective effects of Ginkgo biloba against carbon tetrachloride induced hepatic injury in rats",
abstract = "Objectives: To assess the protective activity of Ginkgo biloba (GB) against CCl4 induced hepatotoxicity in rats and probe into its mechanism of action. Methods: Liver damage was induced in Wistar rats by administering (150-250 g) CCl4 (0.5 ml/kg, i.p.) once daily for 7 days. GB (50 mg/kg, i.p.) was given for one week. Silymarin (200 mg/kg, p.o.) was given as a reference drug. Levels of marker enzymes (AST, ALT, ALP) and total proteins (TP), albumin (Alb) were estimated in serum. A probe into the mechanism of action was attempted by estimating thiobarbituric acid reactive substances (TBARS) and glutathione (GSH) levels in liver homogenates in order to evaluate the degree of lipid peroxidation. Histopathological studies were also done to confirm the biochemical changes. Results: The mean ± SEM serum AST, ALT, ALP levels in control animals were 66.8 ± 4.2, 31.1 ± 2.0 and 445.3 ± 23.1 IU/L respectively whereas in CCl4 treated rats, the level rose to 319.6 ± 22.7, 192.8 ± 16.0 and 809.3 ± 65.3 IU/L respectively. GB reduced the AST, ALT and ALP levels to 55.5 ± 5.3, 36.5 ± 3.6 and 489.6 ± 43.9 IU/L respectively. Silymarin reduced AST, ALT and ALP levels to 51.8 ± 5.2, 30.8 ± 3.4 and 437.8 ± 35.7 IU/L respectively. There was a significant decrease in serum TP and Alb levels after CCl4, which was reversed by GB and silymarin. The tissue mean ± SEM values of TBARS and GSH in control animals were 3.1 ± 0.1 nmol of malondialdehyde/g of wet tissue and 1.9 ± 0.1 mg/g of wet tissue respectively. In CCl4 treated animals, the TBARS and GSH levels were 3.91 ± 0.41 and 1.97 ± 0.11 respectively. GB reduced TBARS to 2.4 ± 0.09 nmol of MDA/g of wet tissue and increased GSH level to 2.4 ± 0.1 mg/g of wet tissue. Silymarin reduced TBARS to 2.1 ± 0.2 nmol of MDA/g of wet tissue and increased GSH level to 2.5 ± 0.17 mg/g of wet tissue. Conclusion: GB has protected the liver from CCl4 damage. Probable mechanism of action is by protection against oxidative damage produced by CCl4.",
author = "{Ashok Shenoy}, K. and Somayaji, {S. N.} and Bairy, {K. L.}",
year = "2001",
month = "9",
day = "26",
language = "English",
volume = "33",
pages = "260--266",
journal = "Indian Journal of Pharmacology",
issn = "0253-7613",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "4",

}

Hepatoprotective effects of Ginkgo biloba against carbon tetrachloride induced hepatic injury in rats. / Ashok Shenoy, K.; Somayaji, S. N.; Bairy, K. L.

In: Indian Journal of Pharmacology, Vol. 33, No. 4, 26.09.2001, p. 260-266.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hepatoprotective effects of Ginkgo biloba against carbon tetrachloride induced hepatic injury in rats

AU - Ashok Shenoy, K.

AU - Somayaji, S. N.

AU - Bairy, K. L.

PY - 2001/9/26

Y1 - 2001/9/26

N2 - Objectives: To assess the protective activity of Ginkgo biloba (GB) against CCl4 induced hepatotoxicity in rats and probe into its mechanism of action. Methods: Liver damage was induced in Wistar rats by administering (150-250 g) CCl4 (0.5 ml/kg, i.p.) once daily for 7 days. GB (50 mg/kg, i.p.) was given for one week. Silymarin (200 mg/kg, p.o.) was given as a reference drug. Levels of marker enzymes (AST, ALT, ALP) and total proteins (TP), albumin (Alb) were estimated in serum. A probe into the mechanism of action was attempted by estimating thiobarbituric acid reactive substances (TBARS) and glutathione (GSH) levels in liver homogenates in order to evaluate the degree of lipid peroxidation. Histopathological studies were also done to confirm the biochemical changes. Results: The mean ± SEM serum AST, ALT, ALP levels in control animals were 66.8 ± 4.2, 31.1 ± 2.0 and 445.3 ± 23.1 IU/L respectively whereas in CCl4 treated rats, the level rose to 319.6 ± 22.7, 192.8 ± 16.0 and 809.3 ± 65.3 IU/L respectively. GB reduced the AST, ALT and ALP levels to 55.5 ± 5.3, 36.5 ± 3.6 and 489.6 ± 43.9 IU/L respectively. Silymarin reduced AST, ALT and ALP levels to 51.8 ± 5.2, 30.8 ± 3.4 and 437.8 ± 35.7 IU/L respectively. There was a significant decrease in serum TP and Alb levels after CCl4, which was reversed by GB and silymarin. The tissue mean ± SEM values of TBARS and GSH in control animals were 3.1 ± 0.1 nmol of malondialdehyde/g of wet tissue and 1.9 ± 0.1 mg/g of wet tissue respectively. In CCl4 treated animals, the TBARS and GSH levels were 3.91 ± 0.41 and 1.97 ± 0.11 respectively. GB reduced TBARS to 2.4 ± 0.09 nmol of MDA/g of wet tissue and increased GSH level to 2.4 ± 0.1 mg/g of wet tissue. Silymarin reduced TBARS to 2.1 ± 0.2 nmol of MDA/g of wet tissue and increased GSH level to 2.5 ± 0.17 mg/g of wet tissue. Conclusion: GB has protected the liver from CCl4 damage. Probable mechanism of action is by protection against oxidative damage produced by CCl4.

AB - Objectives: To assess the protective activity of Ginkgo biloba (GB) against CCl4 induced hepatotoxicity in rats and probe into its mechanism of action. Methods: Liver damage was induced in Wistar rats by administering (150-250 g) CCl4 (0.5 ml/kg, i.p.) once daily for 7 days. GB (50 mg/kg, i.p.) was given for one week. Silymarin (200 mg/kg, p.o.) was given as a reference drug. Levels of marker enzymes (AST, ALT, ALP) and total proteins (TP), albumin (Alb) were estimated in serum. A probe into the mechanism of action was attempted by estimating thiobarbituric acid reactive substances (TBARS) and glutathione (GSH) levels in liver homogenates in order to evaluate the degree of lipid peroxidation. Histopathological studies were also done to confirm the biochemical changes. Results: The mean ± SEM serum AST, ALT, ALP levels in control animals were 66.8 ± 4.2, 31.1 ± 2.0 and 445.3 ± 23.1 IU/L respectively whereas in CCl4 treated rats, the level rose to 319.6 ± 22.7, 192.8 ± 16.0 and 809.3 ± 65.3 IU/L respectively. GB reduced the AST, ALT and ALP levels to 55.5 ± 5.3, 36.5 ± 3.6 and 489.6 ± 43.9 IU/L respectively. Silymarin reduced AST, ALT and ALP levels to 51.8 ± 5.2, 30.8 ± 3.4 and 437.8 ± 35.7 IU/L respectively. There was a significant decrease in serum TP and Alb levels after CCl4, which was reversed by GB and silymarin. The tissue mean ± SEM values of TBARS and GSH in control animals were 3.1 ± 0.1 nmol of malondialdehyde/g of wet tissue and 1.9 ± 0.1 mg/g of wet tissue respectively. In CCl4 treated animals, the TBARS and GSH levels were 3.91 ± 0.41 and 1.97 ± 0.11 respectively. GB reduced TBARS to 2.4 ± 0.09 nmol of MDA/g of wet tissue and increased GSH level to 2.4 ± 0.1 mg/g of wet tissue. Silymarin reduced TBARS to 2.1 ± 0.2 nmol of MDA/g of wet tissue and increased GSH level to 2.5 ± 0.17 mg/g of wet tissue. Conclusion: GB has protected the liver from CCl4 damage. Probable mechanism of action is by protection against oxidative damage produced by CCl4.

UR - http://www.scopus.com/inward/record.url?scp=0034855414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034855414&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 260

EP - 266

JO - Indian Journal of Pharmacology

JF - Indian Journal of Pharmacology

SN - 0253-7613

IS - 4

ER -